Advanced statistical methods and designs for clinical trials for COVID-19.
作者信息
Shan Guogen, Wang Weizhen
机构信息
Epidemiology and Biostatistics Program, Department of Environmental and Occupational Health, School of Public Health, University of Nevada Las Vegas, Las Vegas, 89154, NV, USA.
Department of Mathematics and Statistics, Wright State University, Dayton, OH 45435, USA.
出版信息
Int J Antimicrob Agents. 2021 Jan;57(1):106167. doi: 10.1016/j.ijantimicag.2020.106167.
Abstract
摘要
相似文献
1
Advanced statistical methods and designs for clinical trials for COVID-19.
Int J Antimicrob Agents. 2021 Jan;57(1):106167. doi: 10.1016/j.ijantimicag.2020.106167.
2
Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
Int J Antimicrob Agents. 2021 Jan;57(1):106172. doi: 10.1016/j.ijantimicag.2020.106172.
3
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
Int J Antimicrob Agents. 2021 Jan;57(1):106240. doi: 10.1016/j.ijantimicag.2020.106240.
4
Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
Int J Antimicrob Agents. 2021 Jan;57(1):106236. doi: 10.1016/j.ijantimicag.2020.106236.
5
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
Int J Antimicrob Agents. 2021 Jan;57(1):106169. doi: 10.1016/j.ijantimicag.2020.106169.
6
Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Int J Antimicrob Agents. 2021 Jan;57(1):106174. doi: 10.1016/j.ijantimicag.2020.106174.
7
Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
Int J Antimicrob Agents. 2021 Jan;57(1):106171. doi: 10.1016/j.ijantimicag.2020.106171.
8
Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
Int J Antimicrob Agents. 2021 Jan;57(1):106176. doi: 10.1016/j.ijantimicag.2020.106176.
9
Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
Int J Antimicrob Agents. 2021 Jan;57(1):106175. doi: 10.1016/j.ijantimicag.2020.106175.
10
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
Int J Antimicrob Agents. 2021 Jan;57(1):106242. doi: 10.1016/j.ijantimicag.2020.106242.
引用本文的文献
1
Functional and Clinical Outcomes in Acute Wound Management: Measuring the Impact of Negative Pressure Wound Therapy and Specialized Physical Therapy.
Life (Basel). 2025 Mar 21;15(4):511. doi: 10.3390/life15040511.
2
Continuity corrected score confidence interval for the difference in proportions in paired data.
J Appl Stat. 2022 Sep 14;51(1):139-152. doi: 10.1080/02664763.2022.2118245. eCollection 2024.
3
Response adaptive randomization design for a two-stage study with binary response.
J Biopharm Stat. 2023 Sep 3;33(5):575-585. doi: 10.1080/10543406.2023.2170399. Epub 2023 Feb 3.
4
Effects of dose change on the success of clinical trials.
Contemp Clin Trials Commun. 2022 Sep 5;30:100988. doi: 10.1016/j.conctc.2022.100988. eCollection 2022 Dec.
5
Conservative confidence intervals for the intraclass correlation coefficient for clustered binary data.
J Appl Stat. 2021 Apr 2;49(10):2535-2549. doi: 10.1080/02664763.2021.1910939. eCollection 2022.
6
New Confidence Intervals for Relative Risk of Two Correlated Proportions.
Stat Biosci. 2023;15(1):1-30. doi: 10.1007/s12561-022-09345-7. Epub 2022 May 20.
7
Machine learning methods to predict amyloid positivity using domain scores from cognitive tests.
Sci Rep. 2021 Mar 1;11(1):4822. doi: 10.1038/s41598-021-83911-9.
8
Optimal two-stage designs based on restricted mean survival time for a single-arm study.
Contemp Clin Trials Commun. 2021 Jan 23;21:100732. doi: 10.1016/j.conctc.2021.100732. eCollection 2021 Mar.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
Zotero 插件